Mariola Lledó Amat
Las Palmas de Gran Canaria, Las Palmas, 35016, Spain
Location status: Recruiting
NCT Number: NCT05853952
To evaluate whether NESA microcurrents can be used as an effective treatment for various sequelae present in stroke patients, specifically in the treatment of spasticity, balance, pain; and whether it affects quality of life, performance of activities of daily living and quality of sleep.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Las Palmas de Gran Canaria, Las Palmas, 35016, Spain
Location status: Recruiting
Pilot study following a randomized controlled trial design, designed to study the feasibility of a study with a larger sample size.
Intervention of 30 stroke participants with an evolution between 6 months and 4 years since the stroke, who are able to stand upright.
These participants will be recruited voluntarily through a campaign in social networks and with the collaboration of local associations and institutions. Once the inclusion and exclusion criteria have been reviewed, they will be randomly assigned to an intervention group and a placebo group. A double-blind recruitment system will be followed in which the physiotherapist and patients will not know whether they are receiving real or simulated stimulation, for this purpose two NESA XSIGNAL® devices will be used in double-blind mode.
Treatment of 20 sessions per patient, of 1 hour duration each, with the NESA X-Signal device.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The electrodes will be placed with the help of gloves and adapted socks for 1 hour, each session, until 13 intervention sessions are completed. In addition, depending on the session, an adhesive electrode will be placed at the level of C7. Characteristics of microcurrents: pulsed monophasic rectangular wave with a pulse of 1.3 s and pause of 300 ms, voltage 3 millivolt and intensity 0.5 μA
The same protocol described for the experimental group will be applied, but microcurrents device which will be previously manipulated and tested with an oscilloscope so that they do not emit electrical currents.
Time frame: Up to 7 weeks
The instrument will be used to measure the change of pain before and after the intervention will be the Visual Analogue Scale (VAS).
Participants will be asked to mark the level of their pain on a 100 mm, no hatched VAS scale marked at one end as "no pain" and at the other as "worst pain imaginable".
Time frame: Up to 7 weeks
The Pittsburgh Sleep Quality Index (PSQI) will be used. It consists of 19 self-administered questions and 5 questions assessed by the patient's partner or roommate (if available). Only the self-administered questions are included in the score.
The higher the total score, the worse the sleep quality. Thus, a total score less than or equal to five on the Pittsburgh scale indicates that, in general, your sleep quality is optimal, while a total score greater than five suggests that you have sleep problems, of greater or lesser severity.
Time frame: Up to 7 weeks
The Stroke-specific quality of life scale ( ECVI-38) is a specific scale for stroke patients. This instrument includes 38 items divided into eight subgroups: physical status, communication, cognition, emotions, feelings, basic activities of daily living, common activities of daily living and socio-familial functioning.
The format presents five response possibilities: 5 represents the worst situation and 1 represents the absence of the problem.
Time frame: Up to 7 weeks
The Barthel index for the level of independence in performing activities of daily living.
The purpose of this questionnaire is to assign a score to each patient based on his or her degree of dependence in performing a series of basic activities. The values assigned to each activity depend on the time taken to perform them and the need for aids to complete them.
activity of daily living include: eating, transferring between chair and bed, personal grooming, toileting, bathing/showering, transferring, going up/down stairs, dressing/dressing, stool control and urine control.
The activities are assessed by assigning a score between 0, 5, 10 and 15 points and the final result can vary between 0 (completely dependent) and 100 points (completely independent).
Time frame: Up to 7 weeks
The Berg balance scale will be used:
A quantitative measure of functional balance status in the elderly that has proven to be a valid, reliable and sensitive tool in hemiplegic patients.
The Berg scale includes 14 items (scored between 0-4) and total scores range from 0 (severe balance impairment) to 56 (optimal balance status).
Time frame: Up to 7 weeks
The modified Ashworth scale for spasticity will be used. A scale used in the clinic to assess muscle spasticity, the modification adds a level that incorporates the angle at which resistance appears and monitors the speed of passive movement with a one-second count.
This scale is easy to use and can assess all joints, has a high degree of reliability and reproducibility. The score is interpreted as follows:
0 No increase in tone
1 slight increase in tone giving a catch when slight increase in muscle tone, manifested by the limb was moved in flexion or extension.
1+ slight increase in muscle tone, manifested by a catch followed by minimal resistance throughout (ROM )
2 more marked increase in tone but more marked increased in muscle tone through most limb easily flexed
3 considerable increase in tone, passive movement difficult
4 limb rigid in flexion or extension
Interested in participating?
Request InfoUniversity of Las Palmas de Gran Canaria
Other
Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae. A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07520032
Brain Diseases, Cardiovascular Diseases
Ajman, Ajman Emirate, United Arab Emirates
View Trial DetailsNCT07579871
Apnea, Brain Diseases
Lund, Skåne County, Sweden
View Trial DetailsNCT07698522
Brain Diseases, Cardiovascular Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT06891690
Adnexal Diseases, Brain Diseases
Poznan, Poland
View Trial Details